Profile picture

Doctor Michaela Meyer

Bayer AG, Wuppertal (Germany)
Follow
Logo ESC

Contributor content

Leveraging translational approaches for accelerated clinical development of vericiguat
Presentation
Leveraging translational approaches for accelerated clinical development of vericiguat
A concentration-QTc analysis of vericiguat
Presentation
A concentration-QTc analysis of vericiguat
Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction
Presentation
Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

ESC 365 is supported by